Vimentin Regulates Chemokine Expression and NOD2 Activation in Brain Endothelium during Group B Streptococcal Infection-Reference-Cited by-同舟云学术

Vimentin Regulates Chemokine Expression and NOD2 Activation in Brain Endothelium during Group B Streptococcal Infection

Published:2021-11-16 Issue:12 Volume:89 Page:
ISSN:0019-9567
Container-title:Infection and Immunity
language:en
Short-container-title:Infect Immun

Author:

Villarreal R.¹,Manzer H. S.¹,Keestra-Gounder A. M.¹^ORCID,Doran K. S.¹^ORCID

Affiliation:

1. Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA

Abstract

Streptococcus agalactiae (group B Streptococcus , or GBS) is an opportunistic pathogen capable of causing invasive disease in susceptible individuals, including the newborn. Currently, GBS is the leading cause of meningitis in the neonatal period.

Funder

HHS | NIH | National Institute of Neurological Disorders and Stroke

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Immunology,Microbiology,Parasitology

Link

https://journals.asm.org/doi/pdf/10.1128/IAI.00340-21

Reference64 articles.

1. Molecular pathogenesis of neonatal group B streptococcal infection: no longer in its infancy

2. Group B Streptococcus Late-Onset Disease: 2003–2010

3. Concepts and Mechanisms: Crossing Host Barriers

4. Defense at the border: the blood–brain barrier versus bacterial foreigners

5. Recent advances in understanding the molecular basis of group BStreptococcusvirulence

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vimentin affects inflammation and neutrophil recruitment in airway epithelium during Streptococcus suis serotype 2 infection;Veterinary Research;2023-01-30

2. Vimentin as a potential target for diverse nervous system diseases;Neural Regeneration Research;2023

3. The Group B Streptococcal Adhesin BspC Interacts with Host Cytokeratin 19 To Promote Colonization of the Female Reproductive Tract;mBio;2022-10-26

4. Targeting the BspC-vimentin interaction to develop anti-virulence therapies during Group B streptococcal meningitis;PLOS Pathogens;2022-03-22